NANO MRNA Co.,Ltd.
4571
Rank in Stocks
#23522
NANO MRNA Co., Ltd. specializes in the discovery, advancement, and... NANO MRNA Co., Ltd. specializes in the discovery, advancement, and manufacturing of pharmaceutical products, employing its innovative micellar nanoparticle platform. Its biopharmaceutical pipeline is primarily geared towards addressing oncological conditions and a range of other severe illnesses. The enterprise also undertakes the full spectrum of activities for anti-cancer medications, from initial scientific investigation to market commercialization, all underpinned by its distinctive micellar nanoparticle approach. Established on June 14, 1996, by Kazunori Kataoka, Teruo Okano, and Ichiro Nakatomi, the firm maintains its principal operations in Tokyo, Japan.
Share Price
$0.45573515
Last synced: 2026-11-10
Market Cap
$41.44M
Change (1 day)
0.00%
Change (1 year)
-55.84%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade NANO MRNA Co.,Ltd. (4571)
Category
Healthcare
EPS for NANO MRNA Co.,Ltd. (4571)
EPS as of June 2026 TTM: $-0.09
According to NANO MRNA Co.,Ltd.'s latest financial reports, its current EPS (TTM) is $-0.09. At the end of 2025 the company had an EPS of $-0.08, a decrease compared to its 2024 EPS of $-0.07.
EPS history for NANO MRNA Co.,Ltd. from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.09 | 6.50% |
| 2025 | $-0.08 | 7.91% |
| 2024 | $-0.07 | -47.94% |
| 2023 | $-0.14 | -36.26% |
| 2022 | $-0.22 | -41.09% |
| 2021 | $-0.38 | 23.36% |
| 2020 | $-0.30 | -13.78% |
| 2019 | $-0.35 | -70.12% |
| 2018 | $-1.18 | 111.77% |
| 2017 | $-0.56 | 5.33% |
| 2016 | $-0.53 | 1,139.11% |
| 2015 | $-0.04 | -85.53% |
| 2014 | $-0.30 | 47.55% |
| 2013 | $-0.20 | -4.76% |
| 2012 | $-0.21 | -51.65% |
| 2011 | $-0.43 | 14.26% |
| 2010 | $-0.38 | -2.71% |
| 2009 | $-0.39 | -22.22% |
| 2008 | $-0.50 | -44.58% |
| 2007 | $-0.91 | -34.39% |
| 2006 | $-1.38 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -18,480.28% |
US
|
|
| $-7.07 | 8,198.12% |
US
|
|
| $-5.29 | 6,108.92% |
AU
|
|
| $12.88 | -15,217.49% |
BE
|
|
| $21.56 | -25,405.16% |
NL
|
Questions about NANO MRNA Co.,Ltd.'s earnings per share (EPS)
What is NANO MRNA Co.,Ltd.'s earnings per share (EPS)?
NANO MRNA Co.,Ltd.'s earnings per share (EPS) over the last twelve months is $-0.09, as of Jun 2026.
What was NANO MRNA Co.,Ltd.'s earnings per share (EPS) in 2025?
In 2025, NANO MRNA Co.,Ltd.'s earnings per share (EPS) was $-0.08, compared with $-0.07 in 2024.
How has NANO MRNA Co.,Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, NANO MRNA Co.,Ltd.'s earnings per share (EPS) was highest in 2024 ($-0.07) and lowest in 2021 ($-0.38).
How does NANO MRNA Co.,Ltd.'s earnings per share (EPS) compare with similar companies?
NANO MRNA Co.,Ltd.'s earnings per share (EPS) ($-0.09) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.